Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew I Stolbach

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|May 3, 2024
In Response to "Comment on Ensuring the Efficacy and Safety of Approved Medications"Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|April 5, 2019
ACMT Position Statement: Addressing Pediatric Cannabis ExposureMaryann Mazer Amirshahi, Michael J Moss, Silas W Smith, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|April 17, 2020
ACMT Position Statement on Prescription Drug ShortagesMaryann Mazer-Amirshahi, Erin R Fox, Lewis S Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2021
Reporting of Infectious Diseases in the United States During the Coronavirus Disease 2019 (COVID-19) PandemicMatthew A Crane, Aleksandra Popovic, Rohan Panaparambil, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|May 16, 2019
ACMT Position Statement: Buprenorphine Administration in the Emergency DepartmentPaul M Wax, Andrew I Stolbach, Evan S Schwarz, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 16, 2019
ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use DisorderRyan Marino, Jeanmarie Perrone, Lewis S Nelson, et al.
The American Journal of Emergency Medicine|April 3, 2016
Bradycardia and hypotension after synthetic cannabinoid use: a case seriesErin M Kane, Jeremiah S Hinson, Candice D Jordan, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 6, 2017
ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency respondersMichael J Moss, Brandon J Warrick, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 27, 2017
ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency RespondersMichael J Moss, Brandon J Warrick, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|July 4, 2020
ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 PandemicBrenna M Farmer, Jon B Cole, Travis D Olives, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|May 3, 2024
In Response to "Comment on Ensuring the Efficacy and Safety of Approved Medications"Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|April 5, 2019
ACMT Position Statement: Addressing Pediatric Cannabis ExposureMaryann Mazer Amirshahi, Michael J Moss, Silas W Smith, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|April 17, 2020
ACMT Position Statement on Prescription Drug ShortagesMaryann Mazer-Amirshahi, Erin R Fox, Lewis S Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2021
Reporting of Infectious Diseases in the United States During the Coronavirus Disease 2019 (COVID-19) PandemicMatthew A Crane, Aleksandra Popovic, Rohan Panaparambil, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|May 16, 2019
ACMT Position Statement: Buprenorphine Administration in the Emergency DepartmentPaul M Wax, Andrew I Stolbach, Evan S Schwarz, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 16, 2019
ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use DisorderRyan Marino, Jeanmarie Perrone, Lewis S Nelson, et al.
The American Journal of Emergency Medicine|April 3, 2016
Bradycardia and hypotension after synthetic cannabinoid use: a case seriesErin M Kane, Jeremiah S Hinson, Candice D Jordan, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 6, 2017
ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency respondersMichael J Moss, Brandon J Warrick, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 27, 2017
ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency RespondersMichael J Moss, Brandon J Warrick, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|July 4, 2020
ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 PandemicBrenna M Farmer, Jon B Cole, Travis D Olives, et al.
Pageof 4